uu.seUppsala universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
In search of the Holy Grail: Folate-targeted nanoparticles for cancer therapy
Uppsala universitet, Teknisk-naturvetenskapliga vetenskapsområdet, Tekniska sektionen, Institutionen för teknikvetenskaper, Nanoteknologi och funktionella material.
VTT Technical Research Center of Finland, Department of Medical Biotechnology, Turku, Finland.
Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm and Childhood Cancer Research Unit, Department of Women's and Children's Health, Astrid Lindgren's Children's Hospital, Karolinska University Hospital, Stockholm.
2011 (engelsk)Inngår i: Biochemical Pharmacology, ISSN 0006-2952, E-ISSN 1356-1839, Vol. 81, nr 8, s. 976-984Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Targeted drug therapy or "smart" drug delivery, potentially combined with simultaneous imaging modalities to monitor the delivery of drugs to specific tissues, is arguably the "holy grail" of pharmacology. Therapeutic approaches that exploit nanoparticles to deliver drugs selectively to cancer cells are currently considered one of the most promising avenues in the area of cancer therapeutics and imaging. The potential to deliver active chemotherapeutic drugs in the vicinity or directly within specific tumors via receptor mediated pathways, and to image tumors through the use of nanoparticles has been conceptually and experimentally shown for several classes of nanoparticles. Nanoparticles functionalized with the vitamin folic acid are of particular interest as a variety of malignant tumors are known to overexpress the folate receptor(s). Indeed, several nanoparticle architectures with improved retention time, administration route, biocompatibility, absorption, and clearance are being proposed and are in late stage clinical development. This commentary highlights some of the most important concepts related to nanoparticles and folate-mediated drug delivery and imaging in cancer research.

sted, utgiver, år, opplag, sider
2011. Vol. 81, nr 8, s. 976-984
Emneord [en]
Nanoparticle, Folic acid, Targeted delivery, Toxicity
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-152660DOI: 10.1016/j.bcp.2011.01.023ISI: 000289036400002PubMedID: 21300030OAI: oai:DiVA.org:uu-152660DiVA, id: diva2:413780
Tilgjengelig fra: 2011-04-29 Laget: 2011-04-29 Sist oppdatert: 2017-12-11bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Garcia-Bennett, Alfonso

Søk i DiVA

Av forfatter/redaktør
Garcia-Bennett, Alfonso
Av organisasjonen
I samme tidsskrift
Biochemical Pharmacology

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 833 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf